| ~ w ~ ~ ~ |
|---|
| Description ofthe charity's trusts |
| Type ofgoverning document Constitution (adopted 21"October 1983,amended 24'" September 1984, 15'"September 2009, 9~September 2013, 22"' September 2014, 21" Se tember 2015, 22"4 Se tember 2016, 25rc Se tember 2018 |
| How the charity is constituted Association |
| Trustee selection methods Trustees are elected to membership ofthe Executive Committee by BIHS Members at the Annual Business Meeting following a call for nominations |
| earlier in the year |
| Additional governance issues (Optional information) |
| You may choose to include additional information, where relevant, about: Ordinary and Associate Membership and Fellowship ofthe BIHS is open to all registered healthcare professionals active in the field of hypertension and cardiovascular disease prevention in the United Kingdom and the Republic of Ireland. Affiliate membership may be granted to healthcare professionals |
| ~ policies and procedures residing outside the United Kingdom and Republic of Ireland at the discretion |
| adopted for the induction ofthe Executive Committee. It includes clinicians, nurses, physiologists and |
| and training oftrustees; other scientists. Applications for membership are considered throughout the |
| ~ the charity's organisationai year. Membership ofthe Society currently stands at 298. Only members and |
| structure and any wider fellows resident in the United Kingdom and Republic of Ireland are eligible for |
| network with which the election to the Executive Committee. |
| charity works; |
| ~ relationship with any related parties; The management ofthe BIHS is undertaken by an elected Executive Committee of9 persons (Trustees), led by the President and Vice President. |
| ~ trustees' consideration of major risks and the system and procedures to manage them. Seven Working Parties have also been established to help the Executive Committee manage the day-to-day activities ofthe Society (at least one Trustee sits on each ofthe Working Parties, which are required to submit regular reports to the Executive Committee on its activities). |
| The major risks to the continuation ofthe Society's programme ofeducational |
| activities are from a decrease in income from its industrial partners (see under |
| 'Reserves Policy'). Minimal fees to cover administration costs only have been |
| introduced for vadous projects. |
| ~ ~ |
| Summary ofthe The object ofthe Charity is to promote the advancement of knowledge and |
| oblecta ofthe charity dissemination of information concerning the pathophysiology, epidemiology, detection, |
| act out in ita governing document investigation and treatment of arterial hypertension and related cardiovascular diseases |
| Summary ofthe main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had ~ Educational Meetings: Each year, the Society aims to run a main Scientific Meeting. Educational programmes are under review and online options are being explored. Various other meetings are held during the year; in collaboration with other cognate societies and/or as ad hoc meetings on specific topics ~ Guidelines and Scientific Statements: The Society is a stakeholder in various National Institute for Clinical Excellence Guidelines relating to cardiovascular disease and issues statements in response to relevant media reports Website: The aids website (~www. bihsoc. or ) provides a valuable educational resource for healthcare professionals working in the field of high blood pressure. These resources have been increased and enhanced over the last few years and |
| TAR April 2009 |
| Page | |||
|---|---|---|---|
| Independent | examiner's report |
||
| Statement oF |
financial | activities | |
| Balance sheet | |||
| Notes to the financial | statements | 4-9 |
| Unrestricted | Unrestricted | |||
|---|---|---|---|---|
| funds | funds | |||
| 2021 | 2020 | |||
| Notes | ||||
| Incornl f49/n: | ||||
| Donations and legacies *' liu |
2,000 | 112 | ||
| Conferences and meetings |
197,394 | 1,259 | ||
| Membership subscriptions |
14.109 | 13.684 | ||
| Somal programmes | ||||
| 3,617 | ||||
| OMRON hcensing agreement |
17,000 | 17,000 | ||
| Exhibition and sponsorship |
13,000 | |||
| Derivative device applications |
11,000 | 2,000 | ||
| Investments | 16,161 | 17,074 | ||
| Total income | 274,281 | 51,129 | ||
| d | ||||
| Charitable aclivities |
159,431 | 100,975 | ||
| Net gains/(losses) on investments |
9 | 70,794 | 32,181 | |
| Net income/(expenditure) | for the year/ | |||
| Net incoming/(outgoing) | resources | 185,644 | (17,665) | |
| Other recognised gains and losses |
||||
| Other gains or losses | 10 | 1,869 | ||
| Net movement in funds |
185,644 | (15,796) | ||
| Fund balances at 1 January | 2021 | 603,336 | 619,132 | |
| Fund balances at 31 December 2021 | 788,980 | 603,336 |
| 2021 | 2020 | |||||||
|---|---|---|---|---|---|---|---|---|
| Notes | f | f | ||||||
| Fixed assets | ||||||||
| Tangible assets | ||||||||
| Current assets | ||||||||
| Debtors | 11 | 16,148 | 13,554 | |||||
| Investments | 12 | 723,330 | 533,963 | |||||
| Cash at bank and | in | hand | 81,088 | 74,477 | ||||
| 820,566 | 621,994 | |||||||
| Creditors: amounts one year |
falling due within | 13 | (31,586) | (18,658) | ||||
| Net current assets | 788,980 | 603,336 | ||||||
| Income funds | ||||||||
| Unrestricted funds |
788,980 | 603,336 | ||||||
| 788,980 | 603,336 |
| Unrestricted | Unrestricted | |||||
|---|---|---|---|---|---|---|
| funds | funds | |||||
| 2021 | 2020 | |||||
| f: | E | |||||
| Donations | and | gifts | 2,000 | 112 | ||
| 4 | Investments | |||||
| Unrestricted | Unreslricied | |||||
| funds | funds | |||||
| 2021 F |
2020f | |||||
| Dividends | and | interest | receivable | 16,161 | '17,074 |
| 6 | Support costs | ||||||
|---|---|---|---|---|---|---|---|
| Support | Governance | 2021 | Support costs | Governance | 2020 | ||
| costs | costs | costs | |||||
| f | 6 | 6 | 6 | f | |||
| Depreciation | 232 | 232 | |||||
| Exchange Losses | 6,347 | 6,347 | |||||
| Admin costs Finance costs |
46,942 962 |
46,942 962 |
45,606 588 |
45,606 588 |
|||
| 54,251 | 54,251 | 46,426 | 46,426 | ||||
| Analysed between |
|||||||
| Charitable acbvities |
54,251 | 54,251 | 46,426 | 46,426 |
| 2021 | 2020 | ||||||
|---|---|---|---|---|---|---|---|
| Number | Number | ||||||
| Tota | I | ||||||
| 9 | Net | gains/(losses) | on investments | ||||
| 2021 | 2020 | ||||||
| Unreatised | gain/(loss) | on COIF account | 70,794 | 32,181 | |||
| 10 | Other gains or losses | ||||||
| 2021 | 2020 | ||||||
| Foreign exchange | gains | 1,869 |
| 11 | Debtors | |||||
|---|---|---|---|---|---|---|
| 2021 | 2020 | |||||
| Amounts falling due |
within one year: | 8 | f | |||
| Trade debtors | 3,258 | 38 | ||||
| Other debtors | 11,828 | 5,615 | ||||
| Prepayments | and accrued income | 1,062 | 7,901 | |||
| 16,148 | 13,554 | |||||
| 12 | Current asset | investments | ||||
| 2021 | 2020 | |||||
| 8 | 6 | |||||
| Unlisted investments |
723,330 | 533,963 | ||||
| 13 | Creditors: amounts | falling due within one year | 2021 | 2020 | ||
| 6 | ||||||
| Other taxation Trade creditors |
and social security | 29,586 | 2,583 2,308 |
|||
| Other creditors | 195 | |||||
| Accruals and | deferred | income | 2,000 | 13,572 | ||
| 31,586 | 18,658 |
| Page | |||
|---|---|---|---|
| Independent | examiner's report |
||
| Statement oF |
financial | activities | |
| Balance sheet | |||
| Notes to the financial | statements | 4-9 |
| Unrestricted | Unrestricted | |||
|---|---|---|---|---|
| funds | funds | |||
| 2021 | 2020 | |||
| Notes | ||||
| Incornl f49/n: | ||||
| Donations and legacies *' liu |
2,000 | 112 | ||
| Conferences and meetings |
197,394 | 1,259 | ||
| Membership subscriptions |
14.109 | 13.684 | ||
| Somal programmes | ||||
| 3,617 | ||||
| OMRON hcensing agreement |
17,000 | 17,000 | ||
| Exhibition and sponsorship |
13,000 | |||
| Derivative device applications |
11,000 | 2,000 | ||
| Investments | 16,161 | 17,074 | ||
| Total income | 274,281 | 51,129 | ||
| d | ||||
| Charitable aclivities |
159,431 | 100,975 | ||
| Net gains/(losses) on investments |
9 | 70,794 | 32,181 | |
| Net income/(expenditure) | for the year/ | |||
| Net incoming/(outgoing) | resources | 185,644 | (17,665) | |
| Other recognised gains and losses |
||||
| Other gains or losses | 10 | 1,869 | ||
| Net movement in funds |
185,644 | (15,796) | ||
| Fund balances at 1 January | 2021 | 603,336 | 619,132 | |
| Fund balances at 31 December 2021 | 788,980 | 603,336 |
| 2021 | 2020 | |||||||
|---|---|---|---|---|---|---|---|---|
| Notes | f | f | ||||||
| Fixed assets | ||||||||
| Tangible assets | ||||||||
| Current assets | ||||||||
| Debtors | 11 | 16,148 | 13,554 | |||||
| Investments | 12 | 723,330 | 533,963 | |||||
| Cash at bank and | in | hand | 81,088 | 74,477 | ||||
| 820,566 | 621,994 | |||||||
| Creditors: amounts one year |
falling due within | 13 | (31,586) | (18,658) | ||||
| Net current assets | 788,980 | 603,336 | ||||||
| Income funds | ||||||||
| Unrestricted funds |
788,980 | 603,336 | ||||||
| 788,980 | 603,336 |
| Unrestricted | Unrestricted | |||||
|---|---|---|---|---|---|---|
| funds | funds | |||||
| 2021 | 2020 | |||||
| f: | E | |||||
| Donations | and | gifts | 2,000 | 112 | ||
| 4 | Investments | |||||
| Unrestricted | Unreslricied | |||||
| funds | funds | |||||
| 2021 F |
2020f | |||||
| Dividends | and | interest | receivable | 16,161 | '17,074 |
| 6 | Support costs | ||||||
|---|---|---|---|---|---|---|---|
| Support | Governance | 2021 | Support costs | Governance | 2020 | ||
| costs | costs | costs | |||||
| f | 6 | 6 | 6 | f | |||
| Depreciation | 232 | 232 | |||||
| Exchange Losses | 6,347 | 6,347 | |||||
| Admin costs Finance costs |
46,942 962 |
46,942 962 |
45,606 588 |
45,606 588 |
|||
| 54,251 | 54,251 | 46,426 | 46,426 | ||||
| Analysed between |
|||||||
| Charitable acbvities |
54,251 | 54,251 | 46,426 | 46,426 |
| 2021 | 2020 | ||||||
|---|---|---|---|---|---|---|---|
| Number | Number | ||||||
| Tota | I | ||||||
| 9 | Net | gains/(losses) | on investments | ||||
| 2021 | 2020 | ||||||
| Unreatised | gain/(loss) | on COIF account | 70,794 | 32,181 | |||
| 10 | Other gains or losses | ||||||
| 2021 | 2020 | ||||||
| Foreign exchange | gains | 1,869 |
| 11 | Debtors | |||||
|---|---|---|---|---|---|---|
| 2021 | 2020 | |||||
| Amounts falling due |
within one year: | 8 | f | |||
| Trade debtors | 3,258 | 38 | ||||
| Other debtors | 11,828 | 5,615 | ||||
| Prepayments | and accrued income | 1,062 | 7,901 | |||
| 16,148 | 13,554 | |||||
| 12 | Current asset | investments | ||||
| 2021 | 2020 | |||||
| 8 | 6 | |||||
| Unlisted investments |
723,330 | 533,963 | ||||
| 13 | Creditors: amounts | falling due within one year | 2021 | 2020 | ||
| 6 | ||||||
| Other taxation Trade creditors |
and social security | 29,586 | 2,583 2,308 |
|||
| Other creditors | 195 | |||||
| Accruals and | deferred | income | 2,000 | 13,572 | ||
| 31,586 | 18,658 |